Azstarys is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 13 years and older [1].
How is Azstarys taken?
Azstarys is taken orally once daily [1]. The medication is available in capsule form [1].
What is the recommended starting dose for Azstarys?
For patients aged 13 and older, the recommended starting dose of Azstarys is 37.5 mg / 1.5 mg (serdexmethylphenidate, dexmethylphenidate) once daily [1].
What is the maximum recommended dose for Azstarys?
The maximum recommended dose of Azstarys is 150 mg / 6 mg (serdexmethylphenidate, dexmethylphenidate) once daily [1]. Dosage adjustments should be made gradually, not exceeding the maximum recommended daily dose [1].
How long does it take for Azstarys to start working?
Azstarys is a prodrug that contains serdexmethylphenidate, which is converted into dexmethylphenidate. This conversion process leads to a delayed release of dexmethylphenidate, allowing for a longer duration of action [2].
How does Azstarys differ from other ADHD medications?
Azstarys contains two forms of dexmethylphenidate: an immediate-release component and a prodrug component (serdexmethylphenidate) that is designed for delayed release [2]. This dual-release mechanism aims to provide symptom control throughout the day.
When does the patent for Azstarys expire?
Information regarding the patent expiry for Azstarys is available on DrugPatentWatch.com [3]. DrugPatentWatch tracks patent information for many pharmaceuticals.